SOLID STATE TRANSFORMATIONS OF PHARMACEUTICAL COMPOUNDS UPON MILLING: LACTOSE & MANNITOL (authorized version)

Similar documents
Characterization of amorphous pharmaceuticals what can you do in the home lab? Michael Evans, Christina Drathen Bruker AXS GmbH, Karlsruhe, Germany

Transformation of Pharmaceutical Compounds upon Milling and Comilling: The Role of T g

PXRD INVESTIGATION OF CHANGES IN DEHYDRATION BEHAVIOR OF GSK HYDRATE AFTER MICRONIZATION

PONKCS. a method for the quantification of phases with Partial Or No Known Crystal Structures. Bruker AXS, Karlsruhe, Germany

Amorphous Quantitation Strategy for Crystalline Drug Substance a GSK Perspective. Peter Varlashkin GSK, Durham, NC, USA PPXRD 11

Water in Food, Lausanne 2004

Thermal Analysis. Dr. Lidia Tajber School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin

An Investigation of Non-Crystalline Materials Using X-ray Powder Diffraction. PPXRD 12 Beijing May 2013 Simon Bates: Triclinic Labs

Garth J. Simpson Department of Chemistry Purdue University

Copyright JCPDS - International Centre for Diffraction Data 2004, Advances in X-ray Analysis, Volume

Studying Amorphous Pharmaceutical Materials by Powder X-Ray Diffraction and other Solid-State Techniques

AN IN SITU HIGH-TEMPERATURE X-RAY DIFFRACTION STUDY OF PHASE TRANSFORMATIONS IN SILVER BEHENATE

Searching for new API Polymorphs Crystal Structure Determination of Pharmaceutical crystals using Electron Diffraction Tomography

CRYSTAL STRUCTURE DETERMINATION OF PHARMACEUTICALS WITH ELECTRON DIFFRACTION

How Many Parameters Can Affect the Solid Form of Cocrystallization Products in Mechanochemical Reactions? A Case Study

Water Disaccharides interactions in saturated solutions and the crystallization conditions

Polymorph Screening Strategies and a Concomitant Polymorph Case Study

Application Note. Raman Spectroscopy Analysis of Crystalline Polymorphs for Pharmaceutical Development

A Review of Scanning Electron Microscopy Investigations in Tellurite Glass Systems

Selective Crystallization of a Novel Polymorph

Application Note. Introduction. Analysis of crystal polymorphism by Raman Spectroscopy for Medicine Development

VITRIFIED BOTTOM ASH SLAG FROM MUNICIPAL SOLID WASTE INCINERATORS - PHASE RELATIONS OF CaO-SiO 2 -Na 2 O OXIDE SYSTEM

Detection and Quantification of Amorphous Content in Pharmaceutical Materials

WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability

Copyright JCPDS-International Centre for Diffraction Data 2006 ISSN Advances in X-ray Analysis, Volume 49

A vapor (or gas) needs a completely enclosed container to have a definite volume; it will readily take on any shape imposed.

Characterization of β and Mg 41 Nd 5 equilibrium phases in Elektron 21 magnesium alloy after long-term annealing

Structure analysis from X-ray powder data using real-space methods and pair distribution function analysis

AMORPHOUS PHARMACEUTICAL SOLIDS

Color polymorphs of aldose reductase inhibitor Epalrestat: configurational, conformational and synthon differences

ICDD Powder Diffraction File Coverage of Polymers Used in Pharmaceutical and Biomedical Applications

Physical Aging and Fragility of Amorphous Sucrose by DSC

Quantitative phase analysis using the Rietveld method for samples in the Ti-Cr binary systems

Quantitation of amorphous content

Available online at Scholars Research Library

Total Scattering Pair Distribution Functions (TSPDF) for Fingerprinting Amorphous Pharmaceuticals

Phase Transition Behavior of Nylon-66, Nylon-48, and Blends

Microstructure characterization of mechanosynthesized CeO 2 stabilized nanocrystalline ZrO 2

Research Article Amorphization, Crystallization, and Magnetic Properties of Melt-Spun SmCo 7 x (Cr 3 C 2 ) x Alloys

POLYMER PHYSICS. Ulf W. Gedde. Kluwer Academic Publishers

Chemical Engineering 160/260 Polymer Science and Engineering. Lecture 17: Kinetics and Thermodynamics of Crystallization February 26, 2001

K Vinodhini, K Srinivasan

THE ANALYSIS OF NON- CRYSTALLINE MATERIALS IN PHARMACEUTICAL FORMULATIONS

HT-XRD in the study of Cu-Li-Mg

University of Szeged Faculty of Pharmacy Department of Pharmaceutical Technology Head: Prof. Dr. Habil. Piroska Szabó-Révész DSc

Supplementary Information

Keywords. Aluminium-based amorphous alloys; melt spinning; crystallization behaviour; microhardness.

PDF Analysis of Batteries Using Diffraction Computed Tomography. David Wragg University of Oslo

The Application of ATD and DSC Methods to Study of the EN AC Alloy Phase Transformations

A. KISHI AND H. TORAYA

ADVANCES IN QUANTITATIVE XRD ANALYSIS FOR CLINKER, CEMENTS, AND CEMENTITIOUS ADDITIONS

Amorphous Content of Common Pharmaceutical Materials

Experiment title: Anomalous X-ray diffraction of ternary Mo-Ru-Si powder alloys. Date of experiment: from: 22/09/04 to: 25/09/04

Low Temperature Synthesis of Spinel Powders by Mechanical Grinding

Dielectric properties of woody hemp core, a lignocellulosic resource: variation with hemicelluloses content

Crystallization kinetics of PHB and its blends 3.1 Introduction

New Developments in Spray-Dried Lactose

SOFT NANOCRYSTALLINE MAGNETIC POWDERS OBTAINED BY MECHANICAL ALLOYING AND ANNEALING

Introduction to Powder Diffraction/Practical Data Collection

Polymorphism of glycine. Thermodynamic and structural aspects. E. Boldyreva, V. Drebushchak, T. Drebushchak, I. Paukov, Yu. Kovalevskaya, E.

XRD, DTA AND DENSITY STUDIES OF LITHIUM BORATE GLASSES CONTAINING COPPER A. A. Soliman

PHARMACEUTICAL AMORPHOUS ORGANIC MATERIALS CHARACTERIZATION BY USING THE DIFFERENTIAL SCANNING CALORIMETRY AND DYNAMIC MECHANICAL ANALYSIS

X-ray Diffraction Analysis of Polymers Expanding Materials Characterization Capabilities Using the ICDD Powder Diffraction File TM

Physical-chemical characterization of a galvanic sludge and its inertization by vitrification using container glass

STRUCTURE AND MAGNETIC PROPERTIES OF THE Zr 30

SYSTEMATIC ERRORS IN LINEAR PSD BASED HTXRD SYSTEMS

Nonisothermal Phase Transformation of the Glassy Composition TeSe 20

Addressing the Amorphous Content Issue in Quantitative Phase Analysis: The Certification of NIST SRM 676a

Polymorph Screening Technology by Controlling Crystallization

Working with Amorphous API s

STUDY OF POLYMORPHIC TRANSFORMATION OF ORNIDAZOLE DRUG BY DIFFERENTIAL SCANNING CALORIMETRY AND OTHER COMPLEMENTARY TECHNIQUES

THE BEHAVIOUR OF THE LATTICE PARAMETERS IN THE Bi-Sn-Zn SYSTEM

AMORPHISATION PROCESS DURING MECHANICAL ALLOYING OF Al-Fe-Ti POWDERS AND CRYSTALLISATION OF THE MILLING PRODUCTS

The Role of Polymer Excipients in Hot Melt Extrusion A Continuous Manufacturing Process

Publication III Elsevier Science. Reprinted with permission from Elsevier.

Absolute quantification of pharmaceuticals: The search of suitable internal standards

Dissolution Enhancement of Active Pharmaceutical Ingredients in Eudragit E100 by Melt Extrusion Coupled with Supercritical Carbon Dioxide

Solubility of Small-molecule Drugs into Polymer Excipients in Hot Melt Extruded Dosage Forms

Discrimination of bassanite and anhydrite III dehydrated from gypsum at different temperatures

ITO. Crystal structure: Cubic, space group Ia3 No. 206, ci80, a = nm, Z = 16

the Phase Diagrams Today s Topics

Characterization of Polymorphic Transitions in a Pharmaceutical by DSC and MDCS

Lesson 8 Publishing XRD Results

THERMAL RESISTANCE AND PHASE TRANSITIONS STUDIES FOR SOME COMPOSITE MATERIALS BASED ON Al 20 3

Studies on the thermal expansion of nanocrystalline boron carbide

Tim Fawcett Cyrus Crowder Fangling Needham Executive Director Principal Scientist Senior Scientist ICDD ICDD ICDD

PDF-4/Organics The SMART Choice

How to Analyze Polymers Using X-ray Diffraction

Electronic Supplementary Information (ESI) Eutectic melting of LiBH 4 KBH 4

Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017

QUANTITATIVE IN-SITU X-RAY DIFFRACTION ANALYSIS OF EARLY HYDRATION OF PORTLAND CEMENT AT DEFINED TEMPERATURES

Consolidation of [(Fe 0:5 Co 0:5 ) 0:75 Si 0:05 B 0:2 ] 96 Nb 4 Metallic Glassy Powder by SPS Method* 1

Hyderabad, India. *Corresponding author

Investigating Differences in Solubility Between Crystalline and Amorphous Forms of Pharmaceuticals

Agilent TRS100 Raman. Quantitative Pharmaceutical Analysis System

Extended abstract High entropy alloys for fusion applications

Characteristics Study on Bi-Pb Based Alloys Quenched from Melt

A study of the crystallization kinetics in Se 68 Ge 22 Pb 10 chalcogenide glass

National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32310

QPA with Partial or No Known Crystal Structures (PONKCS) Innovation with Integrity

Transcription:

Laboratoire de Dynamique et Structure des Matériaux Moléculaires UMR 8024 Université de Lille 1-France SOLID STATE TRANSFORMATIONS OF PHARMACEUTICAL COMPOUNDS UPON MILLING: LACTOSE & MANNITOL (authorized version) V. Caron, J-F. Willart, R. Lefort, J. Lefebvre, M. Descamps PPXRD 08, Glasgow, 04-07 May 2009

This document was presented at PPXRD - Pharmaceutical Powder X-ray Diffraction Symposium Sponsored by The International Centre for Diffraction Data This presentation is provided by the International Centre for Diffraction Data in cooperation with the authors and presenters of the PPXRD symposia for the express purpose of educating the scientific community. All copyrights for the presentation are retained by the original authors. The ICDD has received permission from the authors to post this material on our website and make the material available for viewing. Usage is restricted for the purposes of education and scientific research. PPXRD Website www.icdd.com/ppxrd ICDD Website - www.icdd.com

Phase transformations under milling In the field of A very active field of researches in metallurgy : Sursaturated solid solutions Amorphous alloys (i.e. pharmaceutical compounds) : Nanomaterials MOLECULAR MATERIALS NO Several theoretical approaches developed SYSTEMATIC but INVESTIGATIONS Description of transformation mechanisms Prediction of final states (theoretical or experimental) No universally accepted

Milling of pharmaceutical compounds Pharma field Milling Grain size Solubility, bioavailability G Milling : numerous contradictory effects No systematic investigations In spite of : Importancy of applications Tg Tm T Original aspects of molecular materials (Fundamental studies)

Molecular compounds specificities Contrast between : Weak inter-molecular interactions Strong intra-molecular interactions a b Low Symmetry Important size Molecules cells (often tricl., mono. or ortho.) Low melting temperatures Glass transition temperature close of RT T milling Low kinetics of cryst Easy Quench-Vitrification Very sensitive to mechanical and thermal perturbations

Transfo. on milling of pharmaceutical compounds Materials selection T g >T milling Lactose Tg = 115 C >T mi Mutarotation caramelization T milling RT Mannitol Tg = 13 C < T mi Rich polymorphism T g <T milling

Plan of speech I Milling Characteristics of milling experiments realized at the laboratory II Stable anhydrous α-lactose Solid-state amorphization of αl S Mutarotation ( 13 C NMR) III Mannitol Mannitol δ Mannitol β Polymorphic transformations

Characteristics of milling Pulverisette 7 Fritsch N 2 N 2 ZrO 2 N x 400 rpm milling (20min) pause (10min) Prevention of hygroscopy

Lactose possible solid-state forms Disaccharid often used in Pharmaceutical and Food industries 2 types of molecules of lactose : α-lactose β-lactose Various solid-state forms: Monohydrated α lactose (L α -H 2 O) (stable) Hygroscopic anhydrous α lactose Stable anhydrous α lactose (αl S ) Anhydrous β lactose Molecular compounds α/β with various stœchiometries

Problems encountered for producing amorphous lactose Thermal degradations and caramelization Mutarotation (in solution ) α-lactose β-lactose

Amorphization of αl S under milling NMR 1 H liq PXRD DSC Muta. α 5 C/min α α/β α β β crystal Before milling After recrys After 30h milling After 30 h milling Before milling degradations 7.0 6.5 6.0 10 15 20 25 3080 120 160 200 240 Ch. Shift (ppm) 2 θ (degrees) Temperature ( C) Crystalline α lactose milling Glassy α lactose without degradations recrys Crystalline α/β lactose

Solid-state NMR 13 C : characterization in situ % β Solid NMR C 1 gal C 4 glu C 1 gluc 4 gal 13 C C 1 glu αlactose C 1 glu βlactose Crystalline or amorphous states Intensity (a.u.) crys β lactose C 1 gal C1 glu C 4 gal C 1 glu C 4 glu crys α LS Detection mutarotation Quantification % β in situ 140 120 100 80 60 40 Chemical Shift (ppm) 20 % β = f(t C)

Mutarotation during heating of amorphous αl Solid NMR 132 C β α 13 C Intensity (a.u.) 102 C 85 C 63 C 21,5 C 120 100 80 60 40 Chemical Shift (ppm)

Milling amorphization local melting-quench 70 60 50 Irreversible Tg α/β crystal T = 85 C 55 50 β-lactose (%) 40 30 20 10 0 0 20 40 60 80 100 120 140 160 180 Glassy αl Mutarotation Temperature ( C) 13 C NMR Out of equilibrium Structural relaxation below Tg 30 0 1 2 3 4 Time (h) 13 C NMR T mil < 85 C < T m Local melting / quench 45 40 35 β-lactose (%)

No mutarotation during heating of crystalline αl S Solid NMR 13 C 160 C Intensity (a.u.) 71,5 C 18 C Crystalline αl S 120 100 80 Chemical Shift (ppm) 60 40

Mannitol Characteristics of Mannitol : Acyclic polyol present in seafood, fruits, mushrooms Used as excipient, sweetener, API G Tg = 13 C G liq G δ G α G β Adapted from Burger et al., J. Pharm. Sciences, 2000, 89, 457 0 C Tm δtm αtm β T ( C)

Polymorphic transformation under milling of Mβ and Mδ XRD αβ Mβ δ XRD Mδ αβ Non milled milled 10 h Non milled Milled 52 h, aging 5h milled 10 h, aging 8 days Milled 52 h, aging 17h 10 15 20 25 30 35 40 10 15 20 25 30 35 40 2 θ (degrees) 2 θ (degrees) Mannitol β Aging milling Mannitol α Mannitol β Mannitol δ Room T C

Interpretation of amorphization αl S under milling as a «Driven system*» T eff (1 Dbal T eff = T + ) Dch T eff T melt Milling αl S D bal > D ch T eff > T fusion T milling T Amorphization *Driven alloys, Martin et al, Solid State Physics, 50, p189 (1997)

Interpretations polymorphic transformations mannitol under milling as a Driven system G G liq Adapted from Burger et al., J. Pharm. Sciences, 2000, 89,457 G δ G α Single T eff > T fusion milling Mβ, Mδ glass stop glass Mα milling G β 2 T eff 0 C β Tm δtm αtm β T transition α δ α T ( C) T eff >T m Mβ, Mδ glass T eff < T m glass Mα

Conclusion Crystalline α lactose milling Glassy α lactose without degradations Local quench melting Glassy αl heating Mutarotation Irreversible at T < Tg Glassy αl Out of equilibrium Mannitol β Aging Milling Mannitol α Mannitol β Mannitol δ Room T C States reached are stationary states rather than thermodynamic equilibrium states

Acknowledgements Pr. Marc Descamps Dr. Jean-François Willart Dr. Ronan Lefort Pr. Jacques Lefebvre Dr. Patrick Derollez Mme. Florence Danede M. Dominique Prevost

Publications related to this presentation P. Zhang, N. Klymachyov, S. Brown, J.C. Ellington and P.J. Grandinetti, "Solid state 13C NMR investigations of the glycosidic linkage in a-a trehalose", Solid state Nuclear Magentic Resonance, 1998, 12, pp 221. J.F. Willart, V. Caron, R. Lefort, F. Danède, D. Prévost and M. Descamps, "Athermal character of the solid state amorphization of lactose induced by ball milling", Solid State Communications, 2004, 132, pp. 693. J. Lefebvre, J.F. Willart, V. Caron, R. Lefort, F. Affouard and F. Danede, "Structure determination of the 1/1 α/β mixed lactose by X-ray powder diffraction", Acta Cryst. B, 2005, 61, pp. 455. R. Lefort, V. Caron, J.F. Willart and M. Descamps, "Mutarotational kinetics and glass transition of lactose", Solid State Communications, 2006, 140, pp. 329.

Publications related to this presentation R. Lefort, A. De Gusseme, J.F. Willart, F. Danede and M. Descamps, "Solid State NMR and DSC methods for quantifying the amorphous content in solid dosage forms: an application to ball-milling of trehalose", International Journal of Pharmaceutics, 2004, 280, pp. 209. M. Descamps, J.F. Willart, E. Dudognon and V. Caron, Transformation of Pharmaceutical Compounds upon milling and comilling : The role of Tg, Journal of Pharmaceutical Sciences, 2007, 96, 00, pp. 1-10. J. Rodriguez-Carvajal, T. Roisnel, Fullprof 98 and WinPLOTR: New Windows 95/NT Application for Diffraction, Newletter 20, 1998. H.M. Rietveld, "Line profiles of neutron powder diffraction peaks for structure refinement", Acta Cryst, 1967, 22, pp 151. H.M. Rietveld, "A profile refinement method for nuclear and magnetic structures", J. Appl. Cryst., 1969, 2, pp 65.